Clinical Trials Browser

Interventional × Losartan × Clear all

NCT05077800 2026-04-13

FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Adenocarcinoma

NCT05607017 2026-04-06

Losartan in Prevention of Radiation-Induced Heart Failure

Phase EARLY_PHASE1 Completed

Radiation Fibrosis Syndrome, Breast Neoplasms

NCT06211335 2026-03-12

Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma

Phase 1 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT03900793 2026-02-03

Losartan + Sunitinib in Treatment of Osteosarcoma

Phase 1 Recruiting

Osteosarcoma

NCT04539808 2026-01-14

NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer

Phase 2 Active not recruiting

42 enrolled 13 charts

Gastrointestinal

Pancreatic Adenocarcinoma

NCT07265739 2025-12-11

Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

Phase 2 Not yet recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT01199978 2025-10-01

Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma

Phase 2 Active not recruiting

Neuroma, Acoustic

NCT03563248 2025-10-01

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07160361 2025-09-16

Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB

Phase 4 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06135493 2025-04-24

Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients

Phase 2 Completed

Breast Neoplasms, Peripheral Nervous System Diseases

NCT05365893 2025-04-16

PHL Treatment in Pancreatic Cancer

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT04106856 2025-04-06

SHAPER

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT05861336 2024-12-27

OVERPASS

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT03864042 2024-09-27

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

Phase 1 Completed

56 enrolled 158 charts

Melanoma

NCT05637216 2024-09-03

Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

Phase 2 Recruiting

Radiation Fibrosis Syndrome, Breast Neoplasms, Camurati-Engelmann Syndrome, Fibrosis, Inflammation

NCT06539806 2024-08-06

Clinical Study Evaluating the Effect of Losartan

Phase NA Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT03878524 2024-03-04

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Phase 1 Terminated

BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT03951142 2023-11-01

ImPRESS

Phase 2 Unknown

Brain Neoplasms, Glioblastoma

NCT05871333 2023-07-19

Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients

Phase 2 Unknown

Gastrointestinal

Stomatitis, Colorectal Neoplasms

NCT04447235 2022-08-09

TITAN

Phase 2 Terminated

COVID-19, Neoplasms, Coronavirus Infections

NCT05097248 2021-10-28

Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy

Phase 2 Unknown

Breast Neoplasms

NCT00879879 2021-02-21

Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis

Phase NA Completed

20 enrolled 14 charts

Precancerous Conditions

NCT01821729 2020-09-25

Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer

Phase 2 Unknown

50 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms

NCT01805453 2020-05-08

ASTER

Phase 3 Completed

Edema, Glioblastoma

NCT01276613 2019-05-02

Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas

Phase EARLY_PHASE1 Terminated

Gastrointestinal

Pancreatic Neoplasms

NCT01234922 2018-08-28

Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors

Phase 2 Terminated

6 enrolled 10 charts

Hypertension

NCT00880386 2017-05-02

Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

Phase NA Withdrawn

Radiation Fibrosis Syndrome, Carcinoma, Non-Small-Cell Lung, Dyspnea, Lung Neoplasms

NCT01281787 2014-06-18

PRESAGE

Phase 3 Completed

Atrial Fibrillation, Lung Neoplasms